Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | MBX Biosciences, Inc. Common Stock MBX | Wellington Management Group LLP | 2,937,853 9.220% | 2,937,853 (New Position) | Filing History |
| 2024-11-01 5:38 pm Purchase | 2024-09-30 | 13G | MBX Biosciences, Inc. Common Stock MBX | Hawryluk P. Kent | 1,910,632 5.550% | 1,910,632 (New Position) | Filing History |
| 2024-09-23 6:07 pm Purchase | 2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX | Norwest Venture Partners XVI LP | 2,136,335 6.400% | 2,136,335 (New Position) | Filing History |
| 2024-09-23 6:05 pm Purchase | 2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX | New Enterprise Associates 17, L.P. | 3,614,486 11.400% | 3,614,486 (New Position) | Filing History |
| 2024-09-23 4:34 pm Purchase | 2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX | ORBIMED ADVISORS LLC | 3,812,215 12.000% | 3,812,215 (New Position) | Filing History |
| 2024-09-23 4:00 pm Purchase | 2024-09-13 | 13G | MBX Biosciences, Inc. Common Stock MBX | Deep Track Capital, LP | 3,018,935 9.480% | 3,018,935 (New Position) | Filing History |
| 2024-09-23 10:48 am Purchase | 2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX | Frazier Life Sciences Public Fund, L.P. | 5,985,347 18.800% | 5,985,347 (New Position) | Filing History |
| 2024-09-20 10:13 am Purchase | 2024-09-13 | 13G | MBX Biosciences, Inc. Common Stock MBX | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 1,790,122 5.620% | 1,790,122 (New Position) | Filing History |